AB
MRNS

Amalgamated Bank’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Amalgamated Bank’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,680
Closed -$15K – 3169
2024
Q1 		$15K Sell
1,680
-5,374
-76% -$52.2K ﹤0.01% 2277
2023
Q4 		$77K Sell
7,054
-500
-7% -$3.75K ﹤0.01% 2098
2023
Q3 		$61K Hold
7,554
– – ﹤0.01% 2171
2023
Q2 		$82K Buy
+7,554
New +$64.7K ﹤0.01% 2140
2022
Q2 		– Sell
-6,013
Closed -$56K – 3252
2022
Q1 		$56K Buy
+6,013
New +$59.7K ﹤0.01% 2431
2020
Q3 		– Sell
-3,345
Closed -$34K – 1522
2020
Q2 		$34K Buy
+3,345
New +$30.8K ﹤0.01% 1461

Other funds holding MRNS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Amalgamated Bank's MRNS Position: Q2 2024 in Review

Amalgamated Bank sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2024, closing a stake of 1,680 shares — an estimated $15K sold.

Amalgamated Bank first reported a position in MRNS in Q2 2020 and held it in 6 quarters. The position peaked at $82K in Q2 2023. 90 funds tracked by Wall St. Rank hold MRNS as of Q2 2024.

  • Amalgamated Bank reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 1,680 Marinus Pharmaceuticals, Inc shares in Q2 2024, an estimated $15K.
  • Amalgamated Bank first reported a position in Marinus Pharmaceuticals, Inc in Q2 2020 and held it in 6 quarters.
  • Amalgamated Bank's Marinus Pharmaceuticals, Inc position peaked at $82K in Q2 2023.
  • 90 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.